🟢 CalciMedica is trading 5% up in after-hours trading, with no clear company-specific catalyst identified

CalciMedica is trading 5% up at $0.69 after closing at $0.66 on August 10, 2026, with no clear company-specific catalyst identified for the after-hours move.

• The latest major update remains the July 29 FDA alignment on Auxora’s acute-pancreatitis Phase 2b design.
• Broader indices finished lower and therefore do not clearly explain the upward move.